Wall Street analysts expect that Cooper Companies Inc (NYSE:COO) will announce $582.06 million in sales for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Cooper Companies’ earnings, with the lowest sales estimate coming in at $569.50 million and the highest estimate coming in at $589.00 million. Cooper Companies posted sales of $499.10 million during the same quarter last year, which suggests a positive year-over-year growth rate of 16.6%. The company is scheduled to report its next quarterly earnings results after the market closes on Thursday, March 8th.
According to Zacks, analysts expect that Cooper Companies will report full-year sales of $582.06 million for the current financial year, with estimates ranging from $2.49 billion to $2.56 billion. For the next year, analysts forecast that the business will report sales of $2.67 billion per share, with estimates ranging from $2.57 billion to $2.75 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow Cooper Companies.
Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. During the same quarter in the previous year, the firm earned $2.28 earnings per share. The business’s revenue was up 8.3% on a year-over-year basis.
Several research analysts have weighed in on COO shares. Stifel Nicolaus reissued a “buy” rating and issued a $265.00 price objective (down previously from $275.00) on shares of Cooper Companies in a research report on Friday, December 8th. Cleveland Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. Oppenheimer set a $250.00 price objective on Cooper Companies and gave the stock a “hold” rating in a research report on Friday, December 8th. Raymond James Financial reissued a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a research report on Monday, December 4th. Finally, Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $257.00 price objective on the stock in a research report on Tuesday, November 14th. Eight research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $259.70.
Cooper Companies (NYSE COO) opened at $240.40 on Wednesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies has a 1 year low of $191.64 and a 1 year high of $256.39. The firm has a market capitalization of $11,593.56, a price-to-earnings ratio of 31.97, a price-to-earnings-growth ratio of 1.90 and a beta of 0.61.
The company also recently declared a semiannual dividend, which was paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd were given a dividend of $0.03 per share. The ex-dividend date was Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio is presently 0.80%.
In related news, Director Allan E. Rubenstein sold 6,450 shares of the stock in a transaction dated Friday, January 12th. The stock was sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the sale, the director now owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $229.06, for a total value of $179,812.10. The disclosure for this sale can be found here. Insiders have sold a total of 54,385 shares of company stock worth $12,289,463 in the last ninety days. Insiders own 1.60% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the stock. Motley Fool Asset Management LLC lifted its holdings in Cooper Companies by 2.8% during the 3rd quarter. Motley Fool Asset Management LLC now owns 36,400 shares of the medical device company’s stock worth $8,631,000 after purchasing an additional 1,000 shares in the last quarter. California Public Employees Retirement System lifted its holdings in Cooper Companies by 11.4% during the 3rd quarter. California Public Employees Retirement System now owns 120,582 shares of the medical device company’s stock worth $28,591,000 after purchasing an additional 12,382 shares in the last quarter. Schroder Investment Management Group lifted its holdings in Cooper Companies by 3.4% during the 4th quarter. Schroder Investment Management Group now owns 414,626 shares of the medical device company’s stock worth $90,339,000 after purchasing an additional 13,442 shares in the last quarter. APG Asset Management N.V. purchased a new stake in Cooper Companies during the 3rd quarter worth about $1,612,000. Finally, Synovus Financial Corp lifted its holdings in Cooper Companies by 7.2% during the 3rd quarter. Synovus Financial Corp now owns 9,550 shares of the medical device company’s stock worth $2,266,000 after purchasing an additional 638 shares in the last quarter. 97.45% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Cooper Companies Inc (COO) Expected to Post Quarterly Sales of $582.06 Million” was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thelincolnianonline.com/2018/03/14/cooper-companies-inc-coo-expected-to-post-quarterly-sales-of-582-06-million.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.